Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported OutcomesJessie L. Barnum, Paul Szabolcs, Kathryn S. Torok et al.|Blood|2022Cited by 2
Gastrointestinal Impact and Tool Performance in Juvenile Systemic Sclerosis Using the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract, Version 2.0 AssessmentSophie Stefancic, Kathryn S. Torok, Amanda Robinson et al.|Arthritis Care & Research|2025Cited by 2